Novo diabetes drug tops older medicine at two years – Reuters
 Visit Bulgaria | Novo diabetes drug tops older medicine at two years Reuters By Bill Berkrot NEW YORK (Reuters) - Novo Nordisk A/S's experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a ... New Diabetes Drug Shows Promise in Trial Novo Nordisk's Diabetes Shot Helps Control Blood Sugar, Weight Study: Novo Nordisk's diabetes drug, liraglutide, scores high over ... |
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Sorry, the comment form is closed at this time.